Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEDICOST PHARMACY PPO WILL BE HEADED BY FORMER PCS EXEC IRA SHARENOW

Executive Summary

MEDICOST PHARMACY PPO WILL BE HEADED BY FORMER PCS EXEC IRA SHARENOW as president of the Southfield, Michigan-based pharmacy preferred provider organization (PPO). Sharenow has been with McKesson's PCS subsidiary for the last three years as VP and general manager. In a March 23 release announcing the appointment, Medicost noted that Sharenow, a pharmacist and an attorney, "served for several years with the Pharmaceutical Society of the State of New York [and] for a dozen years as an officer of Blue Cross and Blue Shield of Greater New York" before joining PCS. Medicost operates a prepaid prescription drug benefit service in Michigan as well as in Ohio and Indiana. Medicost's biggest customers include Ford and Chrysler. The pharmacy PPO said it hopes to expand its pharmacy PPO service to a nationwide level over the next few years. Medicost currently has contracts with roughly 600 pharmacies. The organization said it contracts with between 25-33% of pharmacies in a given locale, and attempts to enlist a representative mixture of independent, chain and supermarket pharmacies. The PPO operates on either a fee-for-service or capitated fee-per-customer basis. Medicost reportedly has about 300,000 subscribers who generate annual revenues of approximately $ 30 mil. In addition to the prescription drug benefit service, Medicost offers drug utilization review through an affiliated company, Health Information Design (HID), based in Arlington, Virginia. "With HID's state-of-the-art drug utilization system called DURbase in place, Medicost will offer clients service and savings through a combination of its unique pharmacy managed health care system and the DURbase capability to cut hospitalizations and overall health care costs by substantial reductions in drug induced illness," the company commented. Both Medicost, a three year-old company, and HID, a 17 year-old company, were acquired by Value Health in late 1987. Founded last May by venture capitalist Robert Patricelli with funding from Warburg, Pincus & Company, Value Health currently has about $ 50 mil. in annual revenues. The firm also owns National Foot Care Program, a podiatry PPO serving 250,000 members in Michigan, and American Psych Management, an Arlington, Virginia-based managed health care firm focusing on mental health and substance abuse.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS013486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel